Imugene Limited
Valuation
$63.6M
Funding
$0
Founded
2012
Imugene Limited revenue, team size, customer count, churn, and more in 2026.
Imugene is a clinical stage immuno-oncology company developing a range of new and novel immunotherapies that seek to activate the immune system of cancer patients.
Last updated
Imugene Limited Revenue
We do not have information about Imugene Limited's revenue yet.
Imugene Limited Valuation, Funding Rounds
Imugene Limited's most recent disclosed valuation is $63.6M.
Imugene Limited is a bootstrapped SaaS company, self-funded since its founding in 2012, with no outside investment to date.
| Year | Round | Amount | Valuation | % Sold |
|---|
Imugene Limited Employees & Team Size
We do not have information about Imugene Limited's team yet.
Customers
We do not have customer count information for Imugene Limited yet.
Frequently Asked Questions about Imugene Limited
What is Imugene Limited's revenue?
GetLatka has not confirmed a public revenue figure for Imugene Limited.
How much funding does Imugene Limited have?
Imugene Limited raised $0.
How many employees does Imugene Limited have?
Imugene Limited has 0 employees.
Where is Imugene Limited headquarters?
Imugene Limited is headquartered in Sydney, New South Wales, Australia.
Source Attribution
Source: all data was collected from GetLatka company research and founder interviews. Revenue, funding, team, and customer figures are presented as company-reported or GetLatka-estimated metrics where the profile data identifies them that way.
Company data last updated .